Logo image of POXEL.PA

POXEL SA (POXEL.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:POXEL - FR0012432516 - Common Stock

0.222 EUR
0 (-1.55%)
Last: 11/26/2025, 7:00:00 PM
Fundamental Rating

0

Overall POXEL gets a fundamental rating of 0 out of 10. We evaluated POXEL against 78 industry peers in the Biotechnology industry. POXEL has a bad profitability rating. Also its financial health evaluation is rather negative. POXEL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

POXEL had negative earnings in the past year.
POXEL had a negative operating cash flow in the past year.
POXEL had negative earnings in each of the past 5 years.
POXEL had a negative operating cash flow in each of the past 5 years.
POXEL.PA Yearly Net Income VS EBIT VS OCF VS FCFPOXEL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

The Return On Assets of POXEL (-122.56%) is worse than 78.21% of its industry peers.
Industry RankSector Rank
ROA -122.56%
ROE N/A
ROIC N/A
ROA(3y)-313.52%
ROA(5y)-206.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
POXEL.PA Yearly ROA, ROE, ROICPOXEL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600

1.3 Margins

With a Gross Margin value of 55.65%, POXEL perfoms like the industry average, outperforming 56.41% of the companies in the same industry.
POXEL's Gross Margin has declined in the last couple of years.
POXEL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.62%
GM growth 5YN/A
POXEL.PA Yearly Profit, Operating, Gross MarginsPOXEL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

0

2. Health

2.1 Basic Checks

POXEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
POXEL has more shares outstanding than it did 1 year ago.
POXEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for POXEL has been reduced compared to a year ago.
POXEL.PA Yearly Shares OutstandingPOXEL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
POXEL.PA Yearly Total Debt VS Total AssetsPOXEL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -9.92, we must say that POXEL is in the distress zone and has some risk of bankruptcy.
POXEL has a Altman-Z score of -9.92. This is in the lower half of the industry: POXEL underperforms 71.79% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.92
ROIC/WACCN/A
WACC11.01%
POXEL.PA Yearly LT Debt VS Equity VS FCFPOXEL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 0.78 indicates that POXEL may have some problems paying its short term obligations.
POXEL has a Current ratio of 0.78. This is in the lower half of the industry: POXEL underperforms 71.79% of its industry peers.
A Quick Ratio of 0.78 indicates that POXEL may have some problems paying its short term obligations.
The Quick ratio of POXEL (0.78) is worse than 70.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
POXEL.PA Yearly Current Assets VS Current LiabilitesPOXEL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.78% over the past year.
Looking at the last year, POXEL shows a very strong growth in Revenue. The Revenue has grown by 234.98%.
Measured over the past years, POXEL shows a very negative growth in Revenue. The Revenue has been decreasing by -24.22% on average per year.
EPS 1Y (TTM)64.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.89%
Revenue 1Y (TTM)234.98%
Revenue growth 3Y-20.88%
Revenue growth 5Y-24.22%
Sales Q2Q%433.53%

3.2 Future

The Earnings Per Share is expected to decrease by -21.44% on average over the next years. This is quite bad
Based on estimates for the next years, POXEL will show a very negative growth in Revenue. The Revenue will decrease by -18.07% on average per year.
EPS Next Y-10.48%
EPS Next 2Y-21.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-79.58%
Revenue Next 2Y-18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
POXEL.PA Yearly Revenue VS EstimatesPOXEL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
POXEL.PA Yearly EPS VS EstimatesPOXEL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for POXEL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for POXEL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POXEL.PA Price Earnings VS Forward Price EarningsPOXEL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POXEL.PA Per share dataPOXEL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

POXEL's earnings are expected to decrease with -21.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.44%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for POXEL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POXEL SA

EPA:POXEL (11/26/2025, 7:00:00 PM)

0.222

0 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06
Earnings (Next)04-20 2026-04-20/amc
Inst Owners4.99%
Inst Owner ChangeN/A
Ins Owners3.3%
Ins Owner ChangeN/A
Market Cap11.93M
Revenue(TTM)6.64M
Net Income(TTM)-18.30M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.12
BVpS-1.1
TBVpS-1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -122.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.65%
FCFM N/A
ROA(3y)-313.52%
ROA(5y)-206.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.62%
GM growth 5YN/A
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z -9.92
F-Score6
WACC11.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.89%
EPS Next Y-10.48%
EPS Next 2Y-21.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)234.98%
Revenue growth 3Y-20.88%
Revenue growth 5Y-24.22%
Sales Q2Q%433.53%
Revenue Next Year-79.58%
Revenue Next 2Y-18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y71.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-223.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.94%
OCF growth 3YN/A
OCF growth 5YN/A

POXEL SA / POXEL.PA FAQ

What is the ChartMill fundamental rating of POXEL SA (POXEL.PA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to POXEL.PA.


Can you provide the valuation status for POXEL SA?

ChartMill assigns a valuation rating of 0 / 10 to POXEL SA (POXEL.PA). This can be considered as Overvalued.


What is the profitability of POXEL stock?

POXEL SA (POXEL.PA) has a profitability rating of 0 / 10.


What is the expected EPS growth for POXEL SA (POXEL.PA) stock?

The Earnings per Share (EPS) of POXEL SA (POXEL.PA) is expected to decline by -10.48% in the next year.